Literature DB >> 1388843

Immunity to schistosomes.

A R Capron1.   

Abstract

Significant advances have been made during the past years in our knowledge of schistosomiasis, the second major parasitic disease in the world. The highlights provide a good illustration of the recent progress made in our understanding of immunity in human populations and the regulation of the immune response, and in the approach toward a vaccine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388843     DOI: 10.1016/s0952-7915(06)80033-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

1.  Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.

Authors:  R D Bungiro; M Goldberg; P K Suri; P M Knopf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Expression and characterization of glutathione peroxidase activity in the human blood fluke Schistosoma mansoni.

Authors:  H Mei; A Thakur; J Schwartz; P T Lo Verde
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 3.  Schistosomiasis. Infection versus disease and hypersensitivity versus immunity.

Authors:  A W Cheever
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

4.  Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

Authors:  N Mielcarek; J Cornette; A M Schacht; R J Pierce; C Locht; A Capron; G Riveau
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Changes of cytokine mRNA expression and IgG responses in rats infected with Capillaria hepatica.

Authors:  Dong Kwan Kim; Kyoung Hwan Joo; Myung Sook Chung
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

6.  Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host.

Authors:  C Cêtre; C Pierrot; C Cocude; S Lafitte; A Capron; M Capron; J Khalife
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.